"Designing Growth Strategies is in our DNA"

Sickle Cell Disease Treatment Market Size, Share & COVID-19 Impact Analysis, By Treatment Modality [Bone Marrow Transplant, Blood Transfusion, Pharmacotherapy {Hydroxyurea, Branded Products (Endari, Adakveo, Oxbryta, Zynteglo, PYRUKYND (Mitapivat), CTX001, Inclacumab, MGTA-145, Vamifeport (VIT-2763), ALXN1820, and FT-4202)}], By End-user (Hospitals, Specialty Clinics, and Others), and Forecast, 2022-2029

Region : Global | Format: PDF | Report ID: FBI101009

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Sickle Cell Disease, For Key Countries/ Regions
    2. Addressable Patient Population – For Branded Drugs
    3. Overview – Branded Drugs (Marketed)
    4. Pipeline Analysis
    5. New Product Launches
    6. Key Industry Developments (Mergers, Acquisitions, Partnership; etc.)
    7. Impact of COVID-19 on the Market
  5. Global Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Treatment Modality
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Endari
          2. Adakveo
          3. Oxbryta
          4. PYRUKYND (Mitapivat)
          5. Zynteglo
          6. CTX001
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
    3. Market Analysis, Insights and Forecast – By Country/Region
      1. U.S.
      2. Europe
      3. Rest of the World
  6. U.S. Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2018-2029
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Endari
          2. Adakveo
          3. Oxbryta
          4. PYRUKYND (Mitapivat)
          5. Zynteglo
          6. CTX001
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
    1. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  7. Europe Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Treatment Modality
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Endari
          2. Adakveo
          3. Oxbryta
          4. PYRUKYND (Mitapivat)
          5. Zynteglo
          6. CTX001
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  8. Rest of the World Sickle Cell Disease Treatment Market Analysis, Insights and Forecast, 2018-2029
    1. Market Analysis, Insights and Forecast – By Treatment Modality
      1. Bone Marrow Transplant
      2. Blood Transfusion
      3. Pharmacotherapy
        1. Hydroxyurea
        2. Branded Products
          1. Adakveo
          2. Oxbryta
          3. Endari
          4. Zynteglo
          5. CTX001
          6. PYRUKYND (Mitapivat)
          7. Inclacumab
          8. Vamifeport (VIT-2763)
          9. ALXN1820
          10. MGTA-145
          11. FT-4202
    2. Market Analysis, Insights and Forecast – By End-user
      1. Hospitals
      2. Specialty Clinics
      3. Others
  9. Competitive Analysis
    1. Global Market Share Analysis (2021)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Bristol-Myers Squibb Company
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Addmedica
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Global Blood Therapeutics, Inc. (Pfizer Inc.)
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Emmaus Medical, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. bluebird bio Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Agios Pharmaceuticals, Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 01: Global Sickle Cell Disease Treatment Market Revenue Breakdown (USD billion,%) by Geography, 2021 & 2029

Figure 02: Global Sickle Cell Disease Treatment Market Value Share (%), By Treatment Modality, 2021 & 2029

Figure 03: Global Sickle Cell Disease Treatment Market Value Share (%), By End-user, 2021 & 2029

Figure 04: Global Sickle Cell Disease Treatment Market Value Share (%), By Geography, 2021 & 2029

Figure 05: U.S. Sickle Cell Disease Treatment Market Value (USD billion), by Treatment Modality, 2021 & 2029

Figure 06: U.S. Sickle Cell Disease Treatment Market Value Share (%), by Treatment Modality, 2021

Figure 07: U.S. Sickle Cell Disease Treatment Market Value (USD billion), by End-user, 2021 & 2029

Figure 08: U.S. Sickle Cell Disease Treatment Market Value Share (%), by End-user, 2021

Figure 09: Europe Sickle Cell Disease Treatment Market Value (USD billion), by Treatment Modality, 2021 & 2029

Figure 10: Europe Sickle Cell Disease Treatment Market Value Share (%), by Treatment Modality, 2021

Figure 11: Europe Sickle Cell Disease Treatment Market Value (USD billion), by End-user, 2021 & 2029

Figure 12: Europe Sickle Cell Disease Treatment Market Value Share (%), by End-user, 2021

Figure 13: Rest of the World Sickle Cell Disease Treatment Market Value (USD billion), by Treatment Modality, 2021 & 2029

Figure 14: Rest of the World Sickle Cell Disease Treatment Market Value Share (%), by Treatment Modality, 2021

Figure 15: Rest of the World Sickle Cell Disease Treatment Market Value (USD billion), by End-user, 2021 & 2029

Figure 16: Rest of the World Sickle Cell Disease Treatment Market Value Share (%), by End-user, 2021

Figure 17: Global Sickle Cell Disease Treatment Market Share (%), by Company, 2021

Table 01: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2018–2029

Table 02: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2018–2029

Table 03: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2018–2029

Table 04: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2018–2029

Table 05: Global Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Geography, 2018–2029

Table 06: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2018–2029

Table 07: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2018–2029

Table 08: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2018–2029

Table 09: U.S. Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2018–2029

Table 10: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2018–2029

Table 11: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2018–2029

Table 12: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2018–2029

Table 13: Europe Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2018–2029

Table 14: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Treatment Modality, 2018–2029

Table 15: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Pharmacotherapy, 2018–2029

Table 16: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By Branded Products, 2018–2029

Table 17: Rest of the World Sickle Cell Disease Treatment Market Revenue (USD billion) Forecast, By End-user, 2018–2029

 

  • Jan, 2023
  • 2021
  • 2018-2020
  • 103

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X